Unexpected therapeutic effects of cisplatin.
Animals
Antineoplastic Agents
/ pharmacology
Biomechanical Phenomena
/ drug effects
Cisplatin
/ pharmacology
Endoplasmic Reticulum Stress
/ drug effects
Humans
Hydrogen-Ion Concentration
/ drug effects
Metabolic Networks and Pathways
/ drug effects
Neoplasms
/ drug therapy
Tumor Microenvironment
/ drug effects
Journal
Metallomics : integrated biometal science
ISSN: 1756-591X
Titre abrégé: Metallomics
Pays: England
ID NLM: 101478346
Informations de publication
Date de publication:
17 07 2019
17 07 2019
Historique:
pubmed:
18
5
2019
medline:
29
5
2020
entrez:
18
5
2019
Statut:
ppublish
Résumé
Cisplatin is a widely used chemotherapeutic agent that is clinically approved to fight both carcinomas and sarcomas. It has relatively high efficiency in treating ovarian cancers and metastatic testicular cancers. It is generally accepted that the major mechanism of cisplatin anti-cancer action is DNA damage. However, cisplatin is also effective in metastatic cancers and should, therefore, affect slow-cycling cancer stem cells in some way. In this review, we focused on the alternative effects of cisplatin that can support a good therapeutic response. First, attention was paid to the effects of cisplatin at the cellular level such as changes in intracellular pH and cellular mechanical properties. Alternative cellular targets of cisplatin, and the effects of cisplatin on cancer cell metabolism and ER stress were also discussed. Furthermore, the impacts of cisplatin on the tumor microenvironment and in the whole organism context were reviewed. In this review, we try to reveal possible causes of the unexpected effectiveness of this anti-cancer drug.
Substances chimiques
Antineoplastic Agents
0
Cisplatin
Q20Q21Q62J
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM